Treatment Refractory and Super-Responders in Psoriasis Biologic Agent Treatment
Researchers sought to recognize and describe the patients with psoriasis at both ends of the biologic agent treatment spectrum.
Researchers sought to recognize and describe the patients with psoriasis at both ends of the biologic agent treatment spectrum.
The composition and functional potential of gut microbiota in patients with psoriasis, including the role of seasonal instability, is examined.
The effect on work productivity of long-term Cal/BD foam treatment for
those with psoriasis is reported on.
The association between flu-like symptoms and the elevation of serum cytokine levels in patients treated with imiquimod cream is examined.
Researchers sought to investigate if an association exists between vaccine derived or wild type rubella virus (RuV) and atypical granulomatous inflammation in otherwise healthy adults.
Ocular symptoms in patients with rosacea–inflammation, dry eye, and surface dysfunction—are quantified.
Researchers sought to treat patients with dermatomyositis (DM) with baricitinib and investigate the results.
The effect of immunosuppressive medications on the effectiveness of the mRNA COVID-19 vaccine in patients with AD, are investigated.
Researchers sought to examine Alopecia Areata Symptom Impact Scale (AASIS) scores and clinician-assessed Severity of Alopecia Tool (SALT) scores and evaluate possible correlations.
The associations of hidradenitis suppurativa and internalized skin bias and a possible association between adverse psychopathological outcomes and impaired HRQOL is investigated.